SCHEMBL24110255

SCHEMBL24110255

COc1ccc2c(ccn2CC(C)(C)N(C)C)c1OC

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.35
TDO2 P48775 5/20 0.34
DHFR P00374 1/20 0.34
SLC2A1 P11166 1/20 0.34
NR3C1 P04150 2/20 0.33
NR3C2 P08235 2/20 0.33
PGR P06401 1/20 0.33
AOC3 Q16853 3/20 0.33
IDO1 P14902 4/20 0.32
TUBB4A P04350 2/20 0.31
TUBB P07437 2/20 0.31
TUBA3C P0DPH7 2/20 0.31
TUBA1B P68363 2/20 0.31
TUBA4A P68366 2/20 0.31
TUBB4B P68371 2/20 0.31
TUBB3 Q13509 2/20 0.31
TUBB2A Q13885 2/20 0.31
TUBB8 Q3ZCM7 2/20 0.31
TUBA3E Q6PEY2 2/20 0.31
TUBA1A Q71U36 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24110262 0.86 GRM2 (0.39) HTR2CDHFRSLC2A1NR3C1NR3C2
SCHEMBL24110256 0.86 NR3C1 (0.35) HTR2CDHFRSLC2A1NR3C1NR3C2
SCHEMBL24110258 0.85 HTR2A (0.35) HTR2CNR3C1NR3C2PGR
SCHEMBL24110313 0.85 NR3C1 (0.36) HTR2CNR3C1NR3C2PGRGRM2
SCHEMBL24109778 0.82 HTR2C (0.55) HTR2CNR3C1NR3C2PGRSMN1; SMN2
SCHEMBL24110326 0.78 TDO2 (0.34) HTR2CTDO2AOC3IDO1TUBB4A
SCHEMBL23927925 0.75 HTR2C (0.47) HTR2CDHFRSLC2A1AOC3SMN1; SMN2
SCHEMBL23927923 0.75 HTR2C (0.47) HTR2CDHFRSLC2A1AOC3SMN1; SMN2
SCHEMBL24110335 0.74 HTR2C (0.40) HTR2CNR3C1TUBB4ATUBBTUBA3C
SCHEMBL24110244 0.74 GRM2 (0.33) HTR2CNR3C1NR3C2PGRGRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. 2023-07-13 US disclosed
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. 2023-07-13 US disclosed
WO-2021252692-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. (US) 2021-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF GAP43, SLC18A2, PNMT HTR2C 35/4885TDO2 1244/4885DHFR 3594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.